Patients should speak with their GP or a specialist obesity service to discuss which treatments are appropriate for their individual circumstances
Among all the weight loss medications available on the market, Glucagon-like peptide-1 (GLP-1) receptor agonists have been the most successful in gaining confidence among consumers [3,4,5]
And somehow, it touches collagen production, wound healing, antioxidant activity, and the expression of thousands of genes at the same time
This condition, called cholelithiasis, occurs in about 10-15% of people undergoing rapid weight loss, whether from surgery, fasting, or medication
Cell Metab 31(2):301312 Cheng W et al (2021) NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity